Faron Pharmaceuticals Oy Stock Price, News & Analysis (LON:FARN)

GBX 830 -2.50 (-0.30 %)
(As of 11/17/2017 02:39 PM ET)
Previous CloseGBX 830
Today's RangeGBX 834 - GBX 810
52-Week RangeGBX 245 - GBX 875
Volume2,726 shs
Average Volume3,449 shs
Market Capitalization£238.35 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Faron Pharmaceuticals Oy (LON:FARN)

Faron Pharmaceuticals Oy logoFaron Pharmaceuticals Oy is a Finland-based biopharmaceutical company engaged in the biotechnology and medical research industry. The Company develops late stage clinical drugs focusing on acute organ traumas, cancer immunotherapy and vascular damage. Its product pipeline includes Traumakine (FP-1201-lyo), an Acute Respiratory Distress Syndrome (ARDS) treatment that is in phase Three development; and Clevegen (FP-1304), an anti-Clever-1 immunotheraphy tumor targeting candidate that is in pre-clinical stage development.


Industry, Sector and Symbol:
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Sector: Bio Therapeutic Drugs
  • Symbol: LON:FARN
  • CUSIP: N/A
  • Web: www.faron.com
Profitability:
  • Trailing EPS: GBX (0.44)
  • Net Margins: -103,042.90%
  • Return on Equity: -141.29%
  • Return on Assets: -86.22%
Misc:
  • Outstanding Shares: 29,160,000
 
Frequently Asked Questions for Faron Pharmaceuticals Oy (LON:FARN)

What is Faron Pharmaceuticals Oy's stock symbol?

Faron Pharmaceuticals Oy trades on the London Stock Exchange (LON) under the ticker symbol "FARN."

Where is Faron Pharmaceuticals Oy's stock going? Where will Faron Pharmaceuticals Oy's stock price be in 2017?

1 brokerages have issued 1-year target prices for Faron Pharmaceuticals Oy's shares. Their predictions range from GBX 723 to GBX 723. On average, they anticipate Faron Pharmaceuticals Oy's share price to reach GBX 723 in the next year. View Analyst Ratings for Faron Pharmaceuticals Oy.

Who are some of Faron Pharmaceuticals Oy's key competitors?

Who are Faron Pharmaceuticals Oy's key executives?

Faron Pharmaceuticals Oy's management team includes the folowing people:

  • Markku Jalkanen, Chief Executive Officer, Founder, Member of the Executive Board
  • Yrjo Erik Kristian Wichmann, Chief Financial Officer, Member of the Executive Board
  • Mikael Maksimow, Vice President Operations
  • Ilse Piippo, Vice President Drug Development, Chief Medical Officer
  • Matti Karvonen, Medical Director
  • Frank Murdoch Armstrong, Non-Executive Chairman of the Board (Age 60)
  • Matti Manner, Non-Executive Vice Chairman of the Board (Age 64)
  • Juho Jalkanen, Non-Executive Director
  • Jonathan Knowles, Non-Executive Director (Age 70)
  • Huaizheng Peng, Non-Executive Director (Age 54)

How do I buy Faron Pharmaceuticals Oy stock?

Shares of Faron Pharmaceuticals Oy and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Faron Pharmaceuticals Oy's stock price today?

One share of Faron Pharmaceuticals Oy stock can currently be purchased for approximately GBX 830.

How big of a company is Faron Pharmaceuticals Oy?

Faron Pharmaceuticals Oy has a market capitalization of £238.35 million.

How can I contact Faron Pharmaceuticals Oy?

Faron Pharmaceuticals Oy's mailing address is Intelligate, Joukahaisenkatu 6, TURKU, 20520, Finland. The company can be reached via phone at +358-2-4695151.


MarketBeat Community Rating for Faron Pharmaceuticals Oy (LON FARN)
Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  79 (Vote Outperform)
Underperform Votes:  45 (Vote Underperform)
Total Votes:  124
MarketBeat's community ratings are surveys of what our community members think about Faron Pharmaceuticals Oy and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Ratings for Faron Pharmaceuticals Oy (LON:FARN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 723
Consensus Price Target History for Faron Pharmaceuticals Oy (LON:FARN)
Price Target History for Faron Pharmaceuticals Oy (LON:FARN)
Analysts' Ratings History for Faron Pharmaceuticals Oy (LON:FARN)
Show:
DateFirmActionRatingPrice TargetDetails
10/2/2017Panmure GordonReiterated RatingBuyView Rating Details
1/4/2016RX SecuritiesInitiated CoverageBuyGBX 375View Rating Details
(Data available from 11/17/2015 forward)

Earnings

Earnings History for Faron Pharmaceuticals Oy (LON:FARN)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Faron Pharmaceuticals Oy (LON:FARN)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Faron Pharmaceuticals Oy (LON:FARN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Faron Pharmaceuticals Oy (LON FARN)
Insider Trades by Quarter for Faron Pharmaceuticals Oy (LON:FARN)
Insider Trades by Quarter for Faron Pharmaceuticals Oy (LON FARN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/11/2017Frank ArmstrongInsiderBuy1,250GBX 800£10,000
9/8/2017Jonathan KnowlesInsiderBuy63,000GBX 725£456,750
4/25/2017Jonathan KnowlesInsiderBuy1,000GBX 635£6,350
3/31/2017Jonathan KnowlesInsiderBuy19,000GBX 550£104,500
12/13/2016Jonathan KnowlesInsiderBuy7,000GBX 275£19,250
12/12/2016Jonathan KnowlesInsiderBuy10,000GBX 265£26,500
9/23/2016Leopoldo ZambelettiInsiderBuy4,000GBX 250£10,000
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Faron Pharmaceuticals Oy (LON:FARN)
Latest Headlines for Faron Pharmaceuticals Oy (LON FARN)
Source:

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Faron Pharmaceuticals Oy (LON FARN) Chart for Friday, November, 17, 2017
Loading chart…

This page was last updated on 11/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.